Six cases of a rare blood clotting disorder have led U.S. health officials to pause the use of Johnson & Johnson's Covid-19 vaccine. Though it's not known if the vaccine is behind the blood clotting, WSJ's Jonathan D. Rockoff says the pause could impact efforts to vaccinate the country.